Online Treatment for HSDD: What Works, What It Costs, and Who Each Option Is For (2026)

This page is for you if your desire used to be higher, the drop bothers you (not just a partner), and you want a clear, honest map of your real options — pill, shot, hormones, or therapy — plus how to get care online without wasting money.

This is not your starting point if you have new pelvic pain, bleeding after menopause, uncontrolled high blood pressure, known heart disease, or liver problems — or if someone is pushing you into this. Those situations need a real exam or an in-person clinician first. We'll flag exactly when online care is the wrong door, because pointing you to the right one is the whole job.

HSDD is low sexual desire that genuinely distresses you and isn't better explained by a medication, a health or mental-health issue, pain, substance use, or your relationship. For the FDA-approved drugs, clinicians look for one specific pattern — "acquired, generalized" HSDD — meaning your desire used to be higher, the drop bothers you, and it happens across situations and partners. If a fixable cause is driving your low desire, a desire drug is usually the wrong, and expensive, answer.

Low sex drive and HSDD are not the same thing. Plenty of women want sex less than they used to. That's normal, and it comes and goes with stress, sleep, age, and life. It only becomes a treatable disorder when it bothers you and it isn't caused by something else. That "bothers you" part matters. If your desire is low but you feel fine about it, you don't have a disorder and you don't need a pill. Full stop.

About 1 in 10 women have HSDD — low desire that causes real distress — while more than a third of women report low desire at some point without that distress. So if this is you, you are far from alone, and you are not broken.

Here's the quick gut-check clinicians use. Answer these privately:

• Did your desire used to feel different, and did it clearly drop?
• Does the low desire bother you — not just someone else?
• Does it happen across the board, no matter the situation or partner?
• Could something else explain it — pain, dryness, a new medication, low mood, poor sleep, heavy stress, or a rough patch in your relationship?

If you answered "yes, yes, yes, and I don't think so," that looks like the picture the FDA-approved drugs treat, and treatment may genuinely help. If a cause jumped out at that last question, that's actually good news — treating the cause is usually cheaper and works better than layering a desire drug on top of it.

(This is a private self-check to help you prepare for a consult. It is not a diagnosis. Only a licensed clinician can diagnose HSDD.)

They help, but modestly. In large trials, Addyi added about half of one to one extra satisfying sexual event per month over a placebo, plus small gains in desire and less distress. Vyleesi improved desire and lowered distress but didn't clearly raise the number of satisfying encounters. These are real, measurable effects — not a light switch for your libido.

The FDA-approved drugs work. They also don't work the way the ads make it feel. Across the big studies, women on Addyi had roughly 0.5 to 1 more satisfying sexual event a month than women on a sugar pill. Independent reviewers who pooled those studies called the effect small and rated the overall evidence low-quality (JAMA Internal Medicine meta-analysis). Vyleesi showed a similar, modest size — it nudged desire and eased distress, but didn't clearly raise the number of satisfying encounters.

Two drugs are FDA-approved for HSDD, and they're not interchangeable. Addyi (flibanserin) is a daily pill for women under 65 — including after menopause, per a December 2025 FDA update. Vyleesi (bremelanotide) is an on-demand injection for premenopausal women only. Both are available through telehealth, though a clinician still has to confirm the drug is right for you.

Think of these as two different tools for two different lives. Here's the full menu a good clinician might weigh — the kind of comparison that usually takes five browser tabs to build.

Big news for older women: as of December 15, 2025, Addyi is FDA-approved for postmenopausal women under 65 — the first pill ever cleared specifically for this group. Vyleesi is still premenopausal-only. If you're postmenopausal, a second evidence-backed route is off-label testosterone. If you're 65 or older, neither drug is FDA-approved for you, so care is handled case by case.

For years, postmenopausal women got a shrug and "that's just aging." That changed. Current Addyi labeling now covers women under 65 with acquired, generalized HSDD, including after menopause — an expansion the FDA granted on December 15, 2025. If you're in that group and you fit the picture, you now have an on-label pill option — not just an off-label workaround.

Online care can be a safe, legitimate start for HSDD when the clinician takes a real history, screens for other causes, reviews your medications, and refers you out when needed. It's the wrong door when your symptoms need a physical exam, urgent attention, or complex medical management. Knowing the difference is how you stay safe.

The risk with online care isn't the internet. It's shallowness. The easiest, fastest, cheapest provider is not always the right one, because the cheapest visit is often the one where nobody asks why your desire changed. When the treatments are this modest, skipping that question is how women end up paying for a drug that was never going to help.

That's exactly why, when we name Midi Health as our top pick below, we do it with eyes open: Midi is not the cheapest single-visit option, and it's not a "just mail me the pink pill" service. If you already know precisely which drug you want and only care about the fastest, cheapest script, a flat-fee clinic will be quicker. But because Midi actually evaluates the cause first, it catches the cases where a pill won't help — and saves you from buying one that won't. When a treatment adds about one good encounter a month, that screening is worth more than the few dollars you'd save rushing. If speed-over-everything is your priority, choosing a flat-fee clinic instead is a fair call — we'd rather tell you than hide it.

Yes. Both FDA-approved drugs — Addyi and Vyleesi — can be prescribed through telehealth after an online visit, then shipped to you, as long as a clinician confirms they're appropriate and you're in a covered state. Which provider fits depends on your state, your insurance, and whether you also want your root causes checked. Here's a verified look at who prescribes what.

We checked each provider's own pages. (The links below are affiliate links.)

Online HSDD treatment has three parts: the visit, the medication, and any labs. The scary "sticker" prices rarely apply. With insurance, Addyi can be as low as $40 a year through the maker's pharmacy; cash, about $149 a month. Vyleesi's maker offers a 4-dose pack for $0–$99. A telehealth visit is separate and often insurance-eligible.

A good online HSDD visit feels more like a careful medical intake than a quick quiz. Expect real questions: when your desire changed, whether it distresses you, whether sex hurts, your menopause stage, your medications, your mood, your relationship, and your blood pressure and health history — so the clinician can tell whether a prescription is safe and likely to help.

Use this as your checklist. A thorough clinician should:

• Separate low libido from HSDD — because one may need no treatment and the other might.
• Ask about pain and dryness — if sex hurts, that gets addressed first.
• Review your medications — antidepressants (SSRIs and SNRIs), some birth control, and certain blood-pressure drugs can lower desire. Never stop a medication on your own; that's a conversation with your prescriber.
• Check safety — blood pressure, liver, heart history, and drug interactions, especially before Addyi or Vyleesi.
• Explain follow-up — for both drugs, you reassess at about 8 weeks and stop if there's no improvement.

If a clinician skips all of this and just offers a script, that's your signal to slow down.

It can feel more private than starting at a local office, but privacy depends on the provider, the pharmacy, and their data policies. Because HSDD care involves sensitive information, it's worth checking each provider's privacy and consumer-health-data policies — and how discreet their texts, emails, and shipping are — before you fill out an intake.

Quick things to check before you share personal details: Does the provider have a clear consumer-health-data policy? Are notifications discreet? Who sees your intake answers? Is shipping plain? Can your data be deleted? You're allowed to ask all of this before you pay.

Our own tool follows the same rule. Before Find My HRT Path asks anything sensitive, it explains what it's for, and we handle your answers under our consumer-health-data and privacy policy. It's built to route you to a safer starting point — not to diagnose you.